Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Didox"”.

  1. DIDOX MODULATES REACTIVE OXYGEN SPECIES PRODUCTION AND INFLAMMATORY EVENTS INDUCED BY LIPOPOLYSACCHARIDE (LPS) AND ARYL HYDROCARBON RECEPTOR (AHR) LIGANDS IN RAW 264.7 MURINE MACROPHAGES.

    … and ageing. It is demonstrated here that Didox (3,4-Dihydroxybenzohydroxamic acid) possesses antioxidative and anti-inflammatory properties that can protect against inflammation and oxidative stress induced by lipopolysaccharide (LPS) and aryl hydrocarbon receptor (AHR) ligands (PCB126, …

    clemson Repository record for DIDOX MODULATES REACTIVE OXYGEN SPECIES PRODUCTION AND INFLAMMATORY EVENTS INDUCED BY LIPOPOLYSACCHARIDE (LPS) AND ARYL HYDROCARBON RECEPTOR (AHR) LIGANDS IN RAW 264.7 MURINE MACROPHAGES. (opens in a new tab)

  2. Targeting ribonucleotide reductase for breast cancer treatment

    … expressed throughout the cell cycle. Didox inhibits ribonucleotide reductase subunit 2 (RRM2) which ultimately blocks DNA synthesis. We have observed that the ribonucleotide reductase subunit 2 (RRM2) is significantly over-expressed in estrogen receptor (ER)–negative cells as compared …

    u-pacific Repository record for Targeting ribonucleotide reductase for breast cancer treatment (opens in a new tab)

  3. Potent and Potentially Non-Cardiotoxic Anthracyclines: Their Synthesis, Biological Evaluation, and Comparison of Hydrozone-Mediated Reductions

    … form, termed 5-imino-13-deoxydoxorubicin (DIDOX), has displayed no cardiotoxic side effects in any clinical setting. However, these structural changes have reduced the potency of the drug more than four-fold. In this work, six different analogs of DIDOX were synthesized and evaluated for in …

    boise Repository record for Potent and Potentially Non-Cardiotoxic Anthracyclines: Their Synthesis, Biological Evaluation, and Comparison of Hydrozone-Mediated Reductions (opens in a new tab)

  4. Resolution of Inflammation Rescues Axon Initial Segment Disruption

    … stage of EAE using the anti-inflammatory drug Didox. However, the potential for Didox directed repair of the AIS in later stages of disease has not been investigated. Here, we utilize two models of CNS inflammation to assess the possibility of reversing AIS pathology. Based on our findings, we …

    vcu Repository record for Resolution of Inflammation Rescues Axon Initial Segment Disruption (opens in a new tab)

  5. Mechanism of tamoxifen resistance in breast cancer

    … cells with the small molecule RRM2 inhibitor Didox significantly reduced cell growth in vitro and in vivo. To further establish a functional association between RRM2 expression and tamoxifen resistance in breast cancer cells, gain of function studies were performed by overexpressing RRM2 in …

    u-pacific Repository record for Mechanism of tamoxifen resistance in breast cancer (opens in a new tab)

  6. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS

    … reductase (RR) inhibitors hydroxyurea (HU), Didox, and Trimidox to synergize, through reduction of nucleotide pools, with the deoxynucleotide analog Ganciclovir (GCV) was examined. A yield reduction assay that utilizes luciferase expressed by a recombinant virus as a surrogate measure of …

    vcu Repository record for INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS (opens in a new tab)